Sunday, October 24, 2021

Broncus Shares Slide in Hong Kong Debut but Raises Almost $200 Million

Must read

Stock Markets1 hour ago (Sep 24, 2021 01:11AM ET)

(C) Reuters.

By Gina Lee – Broncus Holding Corp. (HK:2216) made a disappointing debut on the Hong Kong Stock Exchange on Friday, but still raised HK$1.55 billion ($199.1 million) via its offering.

Shares were steady at HK$15.28 by 1:13 AM ET (5:13 AM GMT). Broncus had priced its IPO at HK$18.70 a share, the top end of its indicative range.

Goldman Sachs (NYSE:GS) (Asia) L.L.C. and Haitong International Securities Company Limited were joint sponsors and joint representatives.

Credit Suisse (SIX:CSGN) (Hong Kong) Limited joined the duo as joint global coordinator, joint bookrunner and joint lead manager.

CMB International Capital Limited, Huatai Financial Holdings (Hong Kong) Limited, China Industrial Securities International Capital Limited and CNCB (Hong Kong) Capital Limited also served as joint bookrunners and joint lead managers.

Broncus will use the offering proceeds for research and development and business expansion. It specializes in diagnosing and treating lung ailments.

Founded in 2012 and based in Hangzhou, the company develops interventional pulmonology products. It also has an integrated interventional pulmonology platform that improves the diagnosis and treatment effects of lung cancer and chronic obstructive pulmonary disease.

The company’s core products include the InterVapor thermal vapor energy ablation system and RF Generator + RF Ablation Catheter that specifically targets lung cancer.

Broncus posted net losses of $32.6 million for 2019 and $48.8 million for 2020, with revenue falling 59% in 2020. The company expects to continue incurring net losses as it boosts R&D efforts and commercializes its products.

It is the latest medical-related company to list in Hong Kong in 2021, including Acotec Scientific Holdings Ltd.’s (HK:6669) HK$1.53 billion IPO In August 2021 and Angelalign Technology Inc.’s (HK:6699) HK$2.72 billion IPO in June 2021.

Broncus Shares Slide in Hong Kong Debut but Raises Almost $200 Million

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Latest article

Subscribe to our newsletter

To be updated with all the latest news, offers and special announcements.